학술논문

Antithrombin III prevents progression of chronic kidney disease following experimental ischaemic-reperfusion injury.
Document Type
Article
Source
Journal of Cellular & Molecular Medicine; Dec2017, Vol. 21 Issue 12, p3506-3514, 9p
Subject
ANTITHROMBIN III
TREATMENT of chronic kidney failure
REPERFUSION injury
ISCHEMIA
DISEASE progression
THERAPEUTICS
Language
ISSN
15821838
Abstract
Copyright of Journal of Cellular & Molecular Medicine is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)